| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Diabetes and HIV: Current Understanding and Future Perspectives
|
Kalra, Sanjay
|
|
2013
|
13 |
3 |
p. 419-427
|
artikel
|
| 2 |
Diabetes and Infections-Hepatitis C: Is There Type 2 Diabetes Excess in Hepatitis C Infection?
|
Naing, Cho
|
|
2013
|
13 |
3 |
p. 428-434
|
artikel
|
| 3 |
Diabetes Mellitus and Inflammation
|
Lontchi-Yimagou, Eric
|
|
2013
|
13 |
3 |
p. 435-444
|
artikel
|
| 4 |
Diabetes Mellitus and Osteoporosis
|
Sealand, Robert
|
|
2013
|
13 |
3 |
p. 411-418
|
artikel
|
| 5 |
Diabetes Mellitus and Periodontal Diseases
|
Sima, Corneliu
|
|
2013
|
13 |
3 |
p. 445-452
|
artikel
|
| 6 |
Do Statins Cause Diabetes?
|
Goldstein, Mark R.
|
|
2013
|
13 |
3 |
p. 381-390
|
artikel
|
| 7 |
Exercise and Diabetes-Related Cardiovascular Disease: Systematic Review of Published Evidence from Observational Studies and Clinical Trials
|
Koivula, Robert W.
|
|
2013
|
13 |
3 |
p. 372-380
|
artikel
|
| 8 |
Hyperglycemia and Vascular Metabolic Memory: Truth or Fiction?
|
Bianchi, Cristina
|
|
2013
|
13 |
3 |
p. 403-410
|
artikel
|
| 9 |
Insulin Use Early in the Course of Type 2 Diabetes Mellitus: The ORIGIN Trial
|
Hanefeld, Markolf
|
|
2013
|
13 |
3 |
p. 342-349
|
artikel
|
| 10 |
Is the Risk and Nature of CVD the Same in Type 1 and Type 2 Diabetes?
|
Duca, Lindsey
|
|
2013
|
13 |
3 |
p. 350-361
|
artikel
|
| 11 |
Nuclear Factor (Erythroid-Derived 2)-Like-2 Factor (Nrf2), a Key Regulator of the Antioxidant Response to Protect Against Atherosclerosis and Nonalcoholic Steatohepatitis
|
Gupte, Anisha A.
|
|
2013
|
13 |
3 |
p. 362-371
|
artikel
|
| 12 |
Risk vs Benefit in Diabetes Pharmacotherapy: a Rational Approach to Choosing Pharmacotherapy in Type 2 Diabetes
|
Cox, Mary Elizabeth
|
|
2013
|
13 |
3 |
p. 319-328
|
artikel
|
| 13 |
The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus
|
Yau, Hanford
|
|
2013
|
13 |
3 |
p. 329-341
|
artikel
|
| 14 |
The Place of GLP-1–Based Therapy in Diabetes Management: Differences Between DPP-4 Inhibitors and GLP-1 Receptor Agonists
|
Eckerle Mize, Dara L.
|
|
2013
|
13 |
3 |
p. 307-318
|
artikel
|
| 15 |
Vascular Calcification in Diabetes: Mechanisms and Implications
|
Snell-Bergeon, Janet K.
|
|
2013
|
13 |
3 |
p. 391-402
|
artikel
|
Tijdschrift beschrijving